BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

738 related articles for article (PubMed ID: 18640976)

  • 1. Mst2 and Lats kinases regulate apoptotic function of Yes kinase-associated protein (YAP).
    Oka T; Mazack V; Sudol M
    J Biol Chem; 2008 Oct; 283(41):27534-27546. PubMed ID: 18640976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor suppressor LATS1 is a negative regulator of oncogene YAP.
    Hao Y; Chun A; Cheung K; Rashidi B; Yang X
    J Biol Chem; 2008 Feb; 283(9):5496-509. PubMed ID: 18158288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling.
    Mana-Capelli S; McCollum D
    J Biol Chem; 2018 Nov; 293(47):18230-18241. PubMed ID: 30266805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deubiquitinating Enzyme USP9X Suppresses Tumor Growth via LATS Kinase and Core Components of the Hippo Pathway.
    Toloczko A; Guo F; Yuen HF; Wen Q; Wood SA; Ong YS; Chan PY; Shaik AA; Gunaratne J; Dunne MJ; Hong W; Chan SW
    Cancer Res; 2017 Sep; 77(18):4921-4933. PubMed ID: 28720576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear localization and pro-apoptotic signaling of YAP2 require intact PDZ-binding motif.
    Oka T; Sudol M
    Genes Cells; 2009 May; 14(5):607-15. PubMed ID: 19371381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics.
    Meliambro K; Wong JS; Ray J; Calizo RC; Towne S; Cole B; El Salem F; Gordon RE; Kaufman L; He JC; Azeloglu EU; Campbell KN
    J Biol Chem; 2017 Dec; 292(51):21137-21148. PubMed ID: 28982981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein.
    Matallanas D; Romano D; Yee K; Meissl K; Kucerova L; Piazzolla D; Baccarini M; Vass JK; Kolch W; O'neill E
    Mol Cell; 2007 Sep; 27(6):962-75. PubMed ID: 17889669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional output of the Salvador/warts/hippo pathway is controlled in distinct fashions in Drosophila melanogaster and mammalian cell lines.
    Zhang X; Milton CC; Humbert PO; Harvey KF
    Cancer Res; 2009 Aug; 69(15):6033-41. PubMed ID: 19584286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation.
    Lin KC; Moroishi T; Meng Z; Jeong HS; Plouffe SW; Sekido Y; Han J; Park HW; Guan KL
    Nat Cell Biol; 2017 Jul; 19(8):996-1002. PubMed ID: 28752853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Furry protein suppresses nuclear localization of yes-associated protein (YAP) by activating NDR kinase and binding to YAP.
    Irie K; Nagai T; Mizuno K
    J Biol Chem; 2020 Mar; 295(10):3017-3028. PubMed ID: 31996378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KIBRA regulates Hippo signaling activity via interactions with large tumor suppressor kinases.
    Xiao L; Chen Y; Ji M; Dong J
    J Biol Chem; 2011 Mar; 286(10):7788-7796. PubMed ID: 21233212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RAC-LATS1/2 signaling regulates YAP activity by switching between the YAP-binding partners TEAD4 and RUNX3.
    Jang JW; Kim MK; Lee YS; Lee JW; Kim DM; Song SH; Lee JY; Choi BY; Min B; Chi XZ; Bae SC
    Oncogene; 2017 Feb; 36(7):999-1011. PubMed ID: 27425596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvador protein is a tumor suppressor effector of RASSF1A with hippo pathway-independent functions.
    Donninger H; Allen N; Henson A; Pogue J; Williams A; Gordon L; Kassler S; Dunwell T; Latif F; Clark GJ
    J Biol Chem; 2011 May; 286(21):18483-91. PubMed ID: 21489991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arhgef7 promotes activation of the Hippo pathway core kinase Lats.
    Heidary Arash E; Song KM; Song S; Shiban A; Attisano L
    EMBO J; 2014 Dec; 33(24):2997-3011. PubMed ID: 25425573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elucidation of a universal size-control mechanism in Drosophila and mammals.
    Dong J; Feldmann G; Huang J; Wu S; Zhang N; Comerford SA; Gayyed MF; Anders RA; Maitra A; Pan D
    Cell; 2007 Sep; 130(6):1120-33. PubMed ID: 17889654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The regulation and function of YAP transcription co-activator.
    Zhu C; Li L; Zhao B
    Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):16-28. PubMed ID: 25487920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway.
    Mo JS; Meng Z; Kim YC; Park HW; Hansen CG; Kim S; Lim DS; Guan KL
    Nat Cell Biol; 2015 Apr; 17(4):500-10. PubMed ID: 25751140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum deprivation inhibits the transcriptional co-activator YAP and cell growth via phosphorylation of the 130-kDa isoform of Angiomotin by the LATS1/2 protein kinases.
    Adler JJ; Johnson DE; Heller BL; Bringman LR; Ranahan WP; Conwell MD; Sun Y; Hudmon A; Wells CD
    Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17368-73. PubMed ID: 24101513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hippo pathway-dependent and -independent roles of RASSF6.
    Ikeda M; Kawata A; Nishikawa M; Tateishi Y; Yamaguchi M; Nakagawa K; Hirabayashi S; Bao Y; Hidaka S; Hirata Y; Hata Y
    Sci Signal; 2009 Sep; 2(90):ra59. PubMed ID: 19797269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control.
    Zhao B; Wei X; Li W; Udan RS; Yang Q; Kim J; Xie J; Ikenoue T; Yu J; Li L; Zheng P; Ye K; Chinnaiyan A; Halder G; Lai ZC; Guan KL
    Genes Dev; 2007 Nov; 21(21):2747-61. PubMed ID: 17974916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.